STEPHID acquired by ANJAC BEAUTY & HEALTH
Context
ANJAC acquired STEPHID to diversify its industrial portfolio into the high-growth luxury fragrance and "niche" perfumery segments. This marks the group's 10th acquisition in six years. The integration allows ANJAC to offer "complementary expertise" (skincare + fragrance) to its existing premium client base. STEPHID benefits from ANJAC's industrial scale to fund capacity expansion while retaining its artisanal identity and current governance.
STEPHID, which reported an EBITDA margin of [members only] in 2023, is valued in this transaction at an EV/EBITDA multiple of [members only], to compare with the average currently observed in the Healthcare & Pharma sector (14.3x).
-> Deep-dive in Healthcare & Pharma market trends
Target
Founded in 1989, STEPHID is a French specialist in the manufacturing, filling, and packaging of luxury perfumes. It serves over 60 high-notoriety brands, specializing in small series and complex manual operations (refined dressings and precise bottle finishing). The company also offers end-to-end logistics for global distribution of finished luxury goods.
Ent. Value
€5–25M
Equity Value
[members only]
Multiples
EV / Revenue
[members only]
EV / EBITDA
[members only]
EV / EBIT
[members only]
Historical Financials (EUR)
Similar deals in Life Sciences
Similar deals in Life Sciences
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 01/2024 | MERCK & CO. | HARPOON THERAPEUTICS | UNITED STATES | R&D Biotech |
| 12/2023 | MARLE GROUP | NOWAK | FRANCE | Implants & Prosthetics |
| 11/2023 | PARAGON | PRIMED | GERMANY | Medical Consumables |
| 11/2023 | AMETEK | PARAGON MEDICAL | UNITED STATES | Medical Devices |
| 10/2023 | LUXEMPART | ALPHACAPS | GERMANY | Nutrition & Dietary Supplements |
| 10/2023 | RESONETICS | NITINOL BUSINESS | UNITED STATES | Medical Devices |
| 08/2023 | ATHOS CONSORTIUM | SCHÜLKE | GERMANY | Medical Consumables |
| 08/2023 | CARL ZEISS MEDITEC | D.O.R.C. (DUTCH OPHTHALMIC RESEARCH CENTER) | NETHERLANDS | Medical Devices |
| 08/2023 | OAKLEY CAPITAL INVESTMENTS | LIBERTY DENTAL GROUP | GERMANY | Implants & Prosthetics |
| 07/2023 | EQT PARTNERS / ADIA | DECHRA PHARMACEUTICALS | UNITED KINGDOM | Pharma & Biotech |
Other operations with ANJAC BEAUTY & HEALTH
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 11/2025 | ANJAC BEAUTY & HEALTH | HEALTH CHAIN GROUP (HCG) | SLOVENIA | CDMO |
| 10/2024 | KKR / KREFELD | ANJAC BEAUTY & HEALTH | FRANCE | CDMO |
| 01/2022 | ANJAC BEAUTY & HEALTH | APOLLO HEALTHCARE CORP. | CANADA | CDMO |
REFERENCES
Revenue range: €5–25M
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of STEPHID by ANJAC BEAUTY & HEALTH are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.